Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Australian Stock Exchange  >  Mayne Pharma Group Limited    MYX   AU000000MYX0

MAYNE PHARMA GROUP LIMITED

(MYX)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: June 2018 2019 2020 2021 2022 2023
Capitalization1 1 361807646596--
Entreprise Value (EV)1 1 6481 088907851830779
P/E ratio -9,50x-2,68x-6,34x-57,6x20,7x9,36x
Yield -----2,25%
Capitalization / Revenue 2,57x1,54x1,41x1,30x1,08x0,96x
EV / Revenue 3,11x2,07x1,98x1,86x1,51x1,26x
EV / EBITDA 9,97x8,31x9,51x9,23x5,74x4,24x
Price to Book 1,11x0,80x0,62x0,58x0,57x0,55x
Nbr of stocks (in thousands) 1 564 7221 582 9371 679 0681 679 068--
Reference price (AUD) 0,870,510,390,360,360,36
Last update 08/23/201808/22/201908/20/202011/29/202011/29/202011/29/2020
1 AUD in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net sales1 530525457458550618
EBITDA1 16513195,392,2145184
Operating profit (EBIT)1 86,237,211,716,867,5118
Operating Margin 16,3%7,08%2,56%3,68%12,3%19,2%
Pre-Tax Profit (EBT)1 -167-354-135-11,524,258,1
Net income1 -134-281-92,8-9,1318,246,8
Net margin -25,3%-53,5%-20,3%-2,00%3,32%7,58%
EPS2 -0,09-0,19-0,06-0,010,020,04
Dividend per Share2 -----0,01
Last update 08/23/201808/22/201908/20/202011/29/202011/29/202011/29/2020
1 AUD in Million
2 AUD
Estimates
Balance Sheet Analysis
Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net Debt1 287280260255234183
Net Cash position1 ------
Leverage (Debt / EBITDA) 1,74x2,14x2,73x2,77x1,62x1,00x
Free Cash Flow1 67,394,743,958,760,863,0
ROE (Net Profit / Equities) 4,77%1,26%-1,25%-1,46%3,16%6,60%
Shareholders' equity1 -2 811-22 2527 397626577709
ROA (Net Profit / Asset) 3,23%0,81%-0,74%1,00%2,37%3,47%
Assets1 -4 153-34 53012 520-9137711 350
Book Value Per Share2 0,780,640,620,610,620,65
Cash Flow per Share2 0,080,070,060,060,070,09
Capex1 54,211,98,9930,033,336,8
Capex / Sales 10,2%2,27%1,97%6,56%6,06%5,96%
Last update 08/23/201808/22/201908/20/202011/24/202011/24/202011/24/2020
1 AUD in Million
2 AUD
Estimates
Finances - Leverage
Financial data source
© 2021 S&P Global Market Intelligence
Key data
Capitalization (AUD)
596 069 186
Capitalization (USD)
460 071 925
Net sales (AUD)
457 000 000
Net sales (USD)
351 995 110
Number of employees
967
Sales / Employee (AUD)
472 596
Sales / Employee (USD)
364 007
Free-Float
81,1%
Free-Float capitalization (AUD)
483 613 544
Free-Float capitalization (USD)
373 273 806
Avg. Exchange 20 sessions (AUD)
344 628
Avg. Exchange 20 sessions (USD)
265 443
Average Daily Capital Traded
0,06%
EPS & Dividend